Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.

Related to this article

Prevnar 20, PCV, Pneumococcal Conjugate Vaccines, Pfizer, Phase 2 Data

October 30th, 2026

Pfizer Reports Strong Phase 2 Data for 25-Valent Pediatric PCV

Phase 2 trial results for the investigational vaccine were presented at IDWeek 2026 in Washington, DC, as the phase 3 program is currently underway.

Vaccine Coadministration, Influenza Vaccine, Flu Shot, COVID-19 Vaccine, Pfizer-BioNTech

October 29th, 2026

COVID-19, Flu Shots Coadministered Are Well-Tolerated in Pregnancy

New survey data add to the evidence regarding the safe and effective route of administering both COVID-19 and flu vaccines simultaneously.

Pfizer-BioNTech, COVID-19 Vaccine, Adverse Events of Special Interest

October 27th, 2026

No Added Adverse Event Risk in Pfizer-BioNTech COVID-19 Vaccine

Researchers provide an update on the adverse events of special interest following patients who received 2024–2025 Pfizer-BioNTech COVID-19 vaccination.

Vaccine Hesitancy, Vaccine Fatigue, Booster Shot, Pharmacist-Led Vaccination, COVID-19 Pandemic, COVID-19 Vaccine

October 22nd, 2026

Vaccine Fatigue May Stall Patient Uptake More Than Hesitancy

Researchers assessed the extent of which vaccine fatigue translates to reduced engagement and adherence among patients.

AI, AI in Pharmacy, Value-Based Care, Pharmacist Scope, Scope of Practice

November 1st, 2026

American Pharmacists Month: Technology’s Role in Expanding Pharmacist Scope

Alyssa Eisenberg, PharmD, explores technology’s emerging role in the health care environment and how the pharmacist of the future’s day-to-day tasks might evolve.

Pharmacy Deserts, Pharmacist Provider Status, Pharmacist Scope of Practice, PBM Reform

October 31st, 2026

American Pharmacists Month: PBM Reform, Provider Status Key in Stopping Pharmacy Deserts

In the final portion of our discussion with Kimberly Kue-Tsemo, PharmD, she explores the key developments that could be the most significant push toward reducing pharmacy deserts.

Pharmacist Scope, Primary Care Teams, Primary Care Pharmacist

October 30th, 2026

American Pharmacists Month: Pharmacists as Care Team Partners Fuels Optimism for the Profession

In the second part of our interview with a collection of pharmacists from various backgrounds, they delve into the current developments highlighting the future of the profession.

DOL Transparency Rule, Finalized DOL Rule, PBM Reform, PBM Transparency

October 30th, 2026

PBMs Must Now Disclose Fees to Employer Plans Under Final DOL Rule

The finalized rule is another step in the right direction for pharmacies calling for reform due to underwater reimbursement and other PBM pressures.

Sending Prescriptions to School: What Patients Need to Know

Articles in this issue

Related to this article

Trending on Drug Topics

American Pharmacists Month: Technology’s Role in Expanding Pharmacist Scope

PBMs Must Now Disclose Fees to Employer Plans Under Final DOL Rule

HHS Lets Pharmacies Compound Peptides as FDA Writes Official Rule

American Pharmacists Month: PBM Reform, Provider Status Key in Stopping Pharmacy Deserts

Pharmacy Law Lowdown: Defending Against PBM Inventory Audits

After the Vote: Healthcare Policy Outlook for Payers, Providers and Patients

Sending Prescriptions to School: What Patients Need to Know

Articles in this issue

Related to this article

Trending on Drug Topics

American Pharmacists Month: Technology’s Role in Expanding Pharmacist Scope

PBMs Must Now Disclose Fees to Employer Plans Under Final DOL Rule

HHS Lets Pharmacies Compound Peptides as FDA Writes Official Rule

American Pharmacists Month: PBM Reform, Provider Status Key in Stopping Pharmacy Deserts

Pharmacy Law Lowdown: Defending Against PBM Inventory Audits